Nymox Pharmaceutical
NYMX
#10166
Rank
S$23.15 M
Marketcap
Country
S$0.25
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): S-$0.08223

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is S-$0.07613. In 2022 the company made an earnings per share (EPS) of S-$0.10 an increase over its 2021 EPS that were of S-$0.19.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$0.08223-18.99%
2022S-$0.10-46.67%
2021S-$0.19-11.76%
2020S-$0.22-15%
2019S-$0.255.26%
2018S-$0.24-26.92%
2017S-$0.33-7.14%
2016S-$0.36-40.43%
2015S-$0.60291.67%
2014S-$0.15-7.69%
2013S-$0.16-43.48%
2012S-$0.29-25.81%
2011S-$0.3955%
2010S-$0.2525%
2009S-$0.200.08%
2008S-$0.20-11.12%
2007S-$0.23-0.16%
2006S-$0.2328.59%
2005S-$0.18-12.49%
2004S-$0.20-16.05%
2003S-$0.2419.07%
2002S-$0.2014.45%
2001S-$0.18-22.16%
2000S-$0.235.64%
1999S-$0.22-34.59%
1998S-$0.33-3.6%
1997S-$0.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.13-18,662.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.73-2,366.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.76-6,348.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.21-38,466.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$10.96-14,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA